United States Drugs for Malaria Market Report 2022
Summary Malaria remains one of the most devastating infectious diseases with approximately 212 million infections and 429,000 deaths each year. In 2016, the revenue is 33.8 M USD.
This report studies sales (consumption) of drugs for malaria in USA market, focuses on top players, with revenue, gross margin and market share for each player, covering Cipla Guilin Pharmaceutical IPCA Laboratories GlaxoSmithKline Mylan Labs Roche Novartis Sanofi Aventis Ajanta Pharma
Split by product types, with revenue, market share and growth rate of each type, can be divided into Aryl Aminoalcohol Compounds Antifolate Compounds Artemisinin Compounds
Split by applications, this report focuses on revenue, market share and growth rate of